Analysis of imported Chikungunya cases in China from 2006 to 2026
Frontiers in Microbiology · 29.05.2026 · 17
DOI: 10.3389/fmicb.2026.1856429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.05.2026. Verfasst von Jiayi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hos…. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chikungunya fever (CHIKF) has impacted 119 countries and regions globally. In 2025, a local outbreak occurred in Guangdong, China, driven by imported cases from Sri Lanka, resulting in over 25,000 diagnoses. This highlights CHIKF as a significant public health concern. Analyzing imported cases in China and discussing travel medicine and related preventive measures is essential.
Methods
This study reviewed literature and reports on CHIKF published in international and Chinese databases, as well as government reports, from 2006 to March 1, 2026. Data related to CHIKF, including case numbers, virus types, source countries, and high-risk provinces, were collected, synthesized, and summarized using descriptive statistical methods. Phylogenetic tree analysis, temporal signal assessment, and mutation analysis were conducted on the Chikungunya virus (CHIKV) sequences sourced from China.
Results
Between 2006 and 2026, China reported a total of 259 imported CHIKF cases, including those from Hong Kong, Macao, and Taiwan. These imported cases contributed to over 25,000 local transmission cases. Among confirmed cases, the East/Central/South African (ECSA) strain was the most prevalent (61.7%), followed by the Asian strain (37.4%). The primary countries of acquisition were Indonesia and Myanmar, with the Asian strain mostly detected in travelers returning from Indonesia, while the ECSA strain was found in travelers from South and Southeast Asia. The rate of evolution for Chinese cases mirrors that of global trends, and no new branches have emerged. The newly identified mutations in recent years exhibit high-frequency variations in the sequences, along with potential unidentified mutations that have appeared.
Conclusion
Returnees from countries with high incidence rates of CHIKF significantly increase the risk of reintroducing the disease to China. An increased number of mutations may enhance the transmission of CHIKV. Therefore, it is crucial to enhance the dissemination of relevant prevention and control measures and expedite vaccine approval to mitigate the incidence of CHIKF among travelers and reduce viral transmission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
- Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Zitieren
APA
Wang, J., Sun, W., Zhao, J., & Zhang, L. (2026). Analysis of imported Chikungunya cases in China from 2006 to 2026. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1856429
Vancouver
Wang J, Sun W, Zhao J, Zhang L. Analysis of imported Chikungunya cases in China from 2006 to 2026. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1856429
BibTeX
@article{Wang2026,
author = {Wang, Jiayi and Sun, Wenxin and Zhao, Junxiang and Zhang, Leiliang},
title = {Analysis of imported Chikungunya cases in China from 2006 to 2026},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1856429}
}
EUVIMED